Accelerate Diagnostics Price to Sales Ratio 2010-2024 | AXDX
Historical PS ratio values for Accelerate Diagnostics (AXDX) over the last 10 years. The current P/S ratio for Accelerate Diagnostics as of November 21, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Accelerate Diagnostics P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-11-20 | 1.70 | 2.64 | |
| 2024-09-30 | 1.71 | $0.64 | 2.66 |
| 2024-06-30 | 1.17 | $0.75 | 1.55 |
| 2024-03-31 | 0.99 | $0.89 | 1.11 |
| 2023-12-31 | 3.92 | $1.02 | 3.83 |
| 2023-09-30 | 5.75 | $1.14 | 5.04 |
| 2023-06-30 | 8.10 | $1.25 | 6.46 |
| 2023-03-31 | 7.00 | $1.49 | 4.68 |
| 2022-12-31 | 7.06 | $1.65 | 4.29 |
| 2022-09-30 | 15.20 | $1.82 | 8.33 |
| 2022-06-30 | 9.93 | $2.00 | 4.98 |
| 2022-03-31 | 14.40 | $1.95 | 7.40 |
| 2021-12-31 | 52.20 | $1.94 | 26.89 |
| 2021-09-30 | 58.30 | $1.95 | 29.83 |
| 2021-06-30 | 80.60 | $2.08 | 38.78 |
| 2021-03-31 | 83.20 | $2.00 | 41.53 |
| 2020-12-31 | 75.80 | $2.00 | 37.90 |
| 2020-09-30 | 106.60 | $2.08 | 51.22 |
| 2020-06-30 | 151.60 | $1.86 | 81.36 |
| 2020-03-31 | 83.30 | $1.81 | 45.98 |
| 2019-12-31 | 169.00 | $1.71 | 99.03 |
| 2019-09-30 | 185.70 | $1.40 | 132.24 |
| 2019-06-30 | 228.80 | $1.24 | 184.79 |
| 2019-03-31 | 210.20 | $1.22 | 172.30 |
| 2018-12-31 | 115.00 | $1.04 | 110.38 |
| 2018-09-30 | 229.50 | $1.10 | 208.71 |
| 2018-06-30 | 223.00 | $1.00 | 223.22 |
| 2018-03-31 | 228.50 | $0.82 | 279.96 |
| 2017-12-31 | 262.00 | $0.77 | 338.33 |
| 2017-09-30 | 224.50 | $0.39 | 575.75 |
| 2017-06-30 | 273.50 | $0.24 | 1116.68 |
| 2017-03-31 | 242.00 | $0.12 | 2044.95 |
| 2016-12-31 | 207.50 | $0.05 | 4319.90 |
| 2016-09-30 | 272.60 | $0.05 | 6015.44 |
| 2016-06-30 | 143.90 | $0.06 | 2351.23 |
| 2016-03-31 | 143.70 | $0.06 | 2334.71 |
| 2015-12-31 | 214.90 | $0.03 | 6542.56 |
| 2015-09-30 | 161.80 | $0.05 | 3512.36 |
| 2015-06-30 | 258.10 | $0.03 | 8873.86 |
| 2015-03-31 | 225.00 | $0.03 | 8086.87 |
| 2014-12-31 | 191.90 | $0.03 | 6846.47 |
| 2014-09-30 | 214.80 | $0.01 | 16381.74 |
| 2014-06-30 | 260.00 | $0.01 | 20338.79 |
| 2014-03-31 | 218.10 | $0.01 | 18816.39 |
| 2013-12-31 | 122.00 | $0.01 | 8878.45 |
| 2013-09-30 | 134.10 | $0.01 | 12711.43 |
| 2013-06-30 | 81.20 | $0.01 | 7678.47 |
| 2013-03-31 | 72.70 | $0.01 | 6720.89 |
| 2012-12-31 | 40.30 | $0.01 | 0.00 |
| 2012-10-31 | 36.00 | $0.02 | 1463.32 |
| 2012-09-30 | 33.30 | $0.03 | 1002.87 |
| 2012-07-31 | 32.70 | $0.04 | 828.87 |
| 2012-06-30 | 26.90 | $0.05 | 573.23 |
| 2012-04-30 | 27.30 | $0.21 | 130.26 |
| 2012-03-31 | 10.50 | $0.20 | 53.11 |
| 2012-01-31 | 12.80 | $0.41 | 30.93 |
| 2011-10-31 | 28.70 | $0.70 | 41.12 |
| 2011-07-31 | 38.90 | $0.95 | 40.97 |
| 2011-04-30 | 38.60 | $0.95 | 40.65 |
| 2011-01-31 | 13.00 | $0.74 | 17.47 |
| 2010-10-31 | 11.00 | $0.50 | 21.93 |
| 2010-07-31 | 8.70 | $0.08 | 104.70 |
| 2010-04-30 | 8.30 | $0.08 | 99.89 |
| 2010-01-31 | 6.80 | $0.34 | 20.21 |
| 2009-10-31 | 12.80 | $0.64 | 19.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.044B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $194.739B | 23.76 |
| Intuitive Surgical (ISRG) | United States | $191.917B | 100.34 |
| Alcon (ALC) | Switzerland | $42.138B | 28.19 |
| Edwards Lifesciences (EW) | United States | $41.404B | 26.29 |
| IQVIA Holdings (IQV) | United States | $34.726B | 19.13 |
| IDEXX Laboratories (IDXX) | United States | $34.092B | 40.15 |
| DexCom (DXCM) | United States | $29.248B | 44.05 |
| STERIS (STE) | Ireland | $20.926B | 24.09 |
| Waters (WAT) | United States | $20.468B | 30.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.297B | 0.00 |
| Hologic (HOLX) | United States | $18.250B | 19.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.969B | 13.31 |
| Sysmex ADR (SSMXY) | Japan | $12.688B | 39.79 |
| Globus Medical (GMED) | United States | $11.345B | 28.73 |
| Penumbra (PEN) | United States | $9.100B | 89.14 |
| Teleflex (TFX) | United States | $8.967B | 14.30 |
| Masimo (MASI) | United States | $8.754B | 42.36 |
| Glaukos (GKOS) | United States | $7.951B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.883B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.479B | 25.38 |
| Veracyte (VCYT) | United States | $3.034B | 91.05 |
| Inari Medical (NARI) | United States | $2.984B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.789B | 16.10 |
| TransMedics (TMDX) | United States | $2.783B | 88.21 |
| Nihon Kohden (NHNKY) | Japan | $2.293B | 17.42 |
| Elekta AB (EKTAY) | Sweden | $2.192B | 17.86 |
| Tandem Diabetes Care (TNDM) | United States | $1.830B | 0.00 |
| RxSight (RXST) | United States | $1.819B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.766B | 9.23 |
| Alphatec Holdings (ATEC) | United States | $1.357B | 0.00 |
| Artivion (AORT) | United States | $1.129B | 74.81 |
| OPKO Health (OPK) | United States | $1.106B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| Paragon 28 (FNA) | United States | $0.879B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.818B | 13.91 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.716B | 0.00 |
| IRadimed (IRMD) | United States | $0.650B | 35.10 |
| OrthoPediatrics (KIDS) | United States | $0.589B | 0.00 |
| AxoGen (AXGN) | United States | $0.561B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.542B | 12.77 |
| SiBone (SIBN) | United States | $0.517B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.483B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.471B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.378B | 20.48 |
| Semler Scientific (SMLR) | United States | $0.337B | 22.60 |
| CVRx (CVRX) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.317B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.303B | 0.00 |
| NeuroPace (NPCE) | United States | $0.274B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.161B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Nevro (NVRO) | United States | $0.159B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.137B | 14.68 |
| Spectral Diagnostics (EDTXF) | Canada | $0.112B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.088B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| 908 Devices (MASS) | United States | $0.086B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.078B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Neuronetics (STIM) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |